• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

紫杉醇洗脱支架与依维莫司洗脱支架同期植入同一冠状动脉内不同病变的比较:光学相干断层成像术 12 个月随访结果。

Comparison of paclitaxel-eluting vs. everolimus-eluting stents implanted simultaneously in different lesions of the same coronary artery: 12-month follow-up with optical coherence tomography.

机构信息

Unidad de Cardiología Intervencionista, Cardiología Valdecilla, Hospital Universitario Marques de Valdecilla, Santander, Spain.

出版信息

EuroIntervention. 2013 Dec;9(8):952-8. doi: 10.4244/EIJV9I8A159.

DOI:10.4244/EIJV9I8A159
PMID:24384292
Abstract

AIMS

Optical coherence tomography (OCT) allows a detailed assessment of intimal coverage and strut apposition which are well known substrates for late thrombosis. This study sought to assess and compare long-term coverage and apposition of PES and EES implanted in different lesions of the same coronary artery (and in the same patient).

METHODS AND RESULTS

A total of 30 patients were included. In these patients PES and EES were implanted in the same vessel in two similar lesions. The selection of the stent for each lesion was random. At 12 months, 30 PES were examined analysing 154±90 struts/stents and 30 EES analysing 158±72 struts/stents. The proportion of uncovered struts was 0.8±1.3% for EES and 1.5±2.9% for PES (p=0.3), and the proportion of malapposed struts was 1.25±2.1% and 0.98±2%, respectively (p=0.2). A pooled analysis was performed using the random effects model, given the significant heterogeneity found, which did not show significant differences between EES and PES for non-coverage (RR 0.73, 95% CI: 0.32-1.67) or malapposition (RR 1.60, 95% CI: 0.56-4.61). The presence of non-coverage in malapposed struts was 62% with PES and 15% with EES (p<0.0001), the maximal malapposition area being significantly larger with PES (0.6±0.3 vs. 0.25±0.2 mm², p=0.001).

CONCLUSIONS

In highly matched conditions, with PES and EES implanted in the same artery, both DES showed a comparable degree of intimal coverage and apposition at one-year follow-up. A smaller area of malapposition with non-covered struts was found with EES.

摘要

目的

光学相干断层扫描(OCT)可对内膜覆盖和支架贴壁情况进行详细评估,这两者是晚期血栓形成的已知底物。本研究旨在评估和比较在同一冠状动脉的不同病变(及同一患者)中植入的 PES 和 EES 的长期覆盖和贴壁情况。

方法和结果

共纳入 30 例患者。这些患者在同一血管的两个类似病变中分别植入 PES 和 EES。每个病变中支架的选择是随机的。12 个月时,对 30 个 PES 进行了检查,共分析了 154±90 个支架/支架;对 30 个 EES 进行了检查,共分析了 158±72 个支架/支架。EES 未覆盖支架的比例为 0.8±1.3%,PES 为 1.5±2.9%(p=0.3);EES 支架贴壁不良的比例为 1.25±2.1%,PES 为 0.98±2%(p=0.2)。鉴于存在显著异质性,使用随机效应模型进行了汇总分析,结果显示 EES 和 PES 之间在非覆盖(RR 0.73,95%CI:0.32-1.67)或支架贴壁不良(RR 1.60,95%CI:0.56-4.61)方面无显著差异。在支架贴壁不良的支架中,PES 有 62%存在非覆盖,EES 有 15%(p<0.0001),最大贴壁不良面积明显更大,PES 为 0.6±0.3 mm²,EES 为 0.25±0.2 mm²(p=0.001)。

结论

在高度匹配的条件下,在同一动脉中植入 PES 和 EES,两种 DES 在一年随访时显示出可比较的内膜覆盖和贴壁程度。EES 中非覆盖支架的贴壁不良面积更小。

相似文献

1
Comparison of paclitaxel-eluting vs. everolimus-eluting stents implanted simultaneously in different lesions of the same coronary artery: 12-month follow-up with optical coherence tomography.紫杉醇洗脱支架与依维莫司洗脱支架同期植入同一冠状动脉内不同病变的比较:光学相干断层成像术 12 个月随访结果。
EuroIntervention. 2013 Dec;9(8):952-8. doi: 10.4244/EIJV9I8A159.
2
Optical coherence tomography evaluation of late strut coverage patterns between first-generation drug-eluting stents and everolimus-eluting stent.第一代药物洗脱支架与依维莫司洗脱支架晚期支架覆盖模式的光学相干断层扫描评估
Catheter Cardiovasc Interv. 2014 Nov 1;84(5):720-6. doi: 10.1002/ccd.25235. Epub 2013 Oct 31.
3
Six-month follow-up evaluation for everolimus-eluting stents by intracoronary optical coherence tomography: comparison with paclitaxel-eluting stents.冠状动脉光学相干断层成像术评价依维莫司洗脱支架 6 个月随访结果:与紫杉醇洗脱支架比较。
Int J Cardiol. 2013 Jun 5;166(1):181-6. doi: 10.1016/j.ijcard.2011.10.102. Epub 2011 Nov 8.
4
Long-term vascular healing in response to sirolimus- and paclitaxel-eluting stents: an optical coherence tomography study.依维莫司和紫杉醇洗脱支架的长期血管愈合:光学相干断层扫描研究。
JACC Cardiovasc Interv. 2012 Sep;5(9):946-57. doi: 10.1016/j.jcin.2012.05.012.
5
Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.光学相干断层扫描评估重叠裸金属支架和药物洗脱支架植入后体内血管反应。
JACC Cardiovasc Interv. 2010 May;3(5):531-9. doi: 10.1016/j.jcin.2010.02.008.
6
Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.应用频域光学相干断层成像术对无保护的左主干冠状动脉远端病变行药物洗脱支架置入后血管相互作用的连续评估。
JACC Cardiovasc Interv. 2013 Oct;6(10):1035-45. doi: 10.1016/j.jcin.2013.05.015.
7
Comparison of early strut coverage between zotarolimus- and everolimus-eluting stents using optical coherence tomography.采用光学相干断层成像术比较依维莫司洗脱支架和佐他莫司洗脱支架的早期支架贴壁情况。
Am J Cardiol. 2013 Jan 1;111(1):1-5. doi: 10.1016/j.amjcard.2012.08.037. Epub 2012 Oct 2.
8
Optical coherence tomography study of healing characteristics of paclitaxel-eluting balloons vs. everolimus-eluting stents for in-stent restenosis: the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) randomised clinical trial.光学相干断层扫描研究紫杉醇洗脱球囊与依维莫司洗脱支架治疗支架内再狭窄的愈合特征:SEDUCE(药物洗脱球囊在冠状动脉再狭窄中的安全性和有效性)随机临床试验。
EuroIntervention. 2014 Aug;10(4):439-48. doi: 10.4244/EIJV10I4A77.
9
Clinical follow-up 3 years after everolimus- and paclitaxel-eluting stents: a pooled analysis from the SPIRIT II (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) and SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trials.依维莫司和紫杉醇洗脱支架置入术后 3 年的临床随访:来自 SPIRIT II(依维莫司洗脱冠状动脉支架系统治疗初发冠状动脉病变的临床评估)和 SPIRIT III(依维莫司洗脱冠状动脉支架系统[EECSS]治疗初发冠状动脉病变患者的临床评估)随机试验的汇总分析。
JACC Cardiovasc Interv. 2010 Dec;3(12):1220-8. doi: 10.1016/j.jcin.2010.07.017.
10
Impact of different stent alloys on human vascular response to everolimus-eluting stent: an optical coherence tomography study: the OCTEVEREST.不同支架合金对依维莫司洗脱支架后人体血管反应的影响:光学相干断层扫描研究:OCTEVEREST。
Catheter Cardiovasc Interv. 2013 Feb;81(3):510-8. doi: 10.1002/ccd.24374. Epub 2012 May 2.

引用本文的文献

1
β-Blockers Reduced the Target Lesion Revascularization After Percutaneous Coronary Intervention Using an Everolimus-eluting Stent.β 受体阻滞剂降低了使用依维莫司洗脱支架经皮冠状动脉介入治疗后的靶病变血运重建。
In Vivo. 2022 Jan-Feb;36(1):416-423. doi: 10.21873/invivo.12719.